{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:25:11Z","timestamp":1790645111121,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,28]]},"DOI":"10.7759\/cureus.22727","type":"journal-article","created":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T06:18:57Z","timestamp":1646115537000},"source":"Crossref","is-referenced-by-count":2,"title":["Reirradiation for Rare Head and Neck Cancers: Orbit, Auditory Organ, and Salivary Glands"],"prefix":"10.7759","author":[{"given":"Hideya","family":"Yamazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Aibe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroya","family":"Shiomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoong-Jin","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoaki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Ogita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh308","article-title":"Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience","volume":"15","author":"Brockstein B","year":"2004","unstructured":"Brockstein B, Haraf DJ, Rademaker AW, et al.. Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience. Ann Oncol. 2004, 15:1179-1186. 10.1093\/annonc\/mdh308","journal-title":"Ann Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032641","article-title":"Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer","volume":"350","author":"Bernier J","year":"2004","unstructured":"Bernier J, Domenge C, Ozsahin M, et al.. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004, 350:1945-1952. 10.1056\/NEJMoa032641","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer","volume":"359","author":"Vermorken JB","year":"2008","unstructured":"Vermorken JB, Mesia R, Rivera F, et al.. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med. 2008, 359:1116-1127. 10.1056\/NEJMoa0802656","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/hed.23542","article-title":"Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate","volume":"37","author":"Strojan P","year":"2015","unstructured":"Strojan P, Corry J, Eisbruch A, et al.. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate. Head Neck. 2015, 37:134-150. 10.1002\/hed.23542","journal-title":"Head Neck"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/hed.26264","article-title":"Reirradiation with intensity-modulated radiation therapy for recurrent or secondary head and neck cancer: meta-analysis and systematic review","volume":"42","author":"Lee J","year":"2020","unstructured":"Lee J, Shin IS, Kim WC, Yoon WS, Koom WS, Rim CH. Reirradiation with intensity-modulated radiation therapy for recurrent or secondary head and neck cancer: meta-analysis and systematic review. Head Neck. 2020, 42:2473-2485. 10.1002\/hed.26264","journal-title":"Head Neck"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.104757","article-title":"Reirradiation using stereotactic body radiotherapy in the management of recurrent or second primary head and neck cancer: a meta-analysis and systematic review","volume":"107","author":"Lee J","year":"2020","unstructured":"Lee J, Kim WC, Yoon WS, Koom WS, Rim CH. Reirradiation using stereotactic body radiotherapy in the management of recurrent or second primary head and neck cancer: a meta-analysis and systematic review. Oral Oncol. 2020, 107:104757. 10.1016\/j.oraloncology.2020.104757","journal-title":"Oral Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2013.05.005","article-title":"Frequency, outcome and prognostic factors of carotid blowout syndrome after hypofractionated re-irradiation of head and neck cancer using CyberKnife: a multi-institutional study","volume":"107","author":"Yamazaki H","year":"2013","unstructured":"Yamazaki H, Ogita M, Kodani N, et al.. Frequency, outcome and prognostic factors of carotid blowout syndrome after hypofractionated re-irradiation of head and neck cancer using CyberKnife: a multi-institutional study. Radiother Oncol. 2013, 107:305-309. 10.1016\/j.radonc.2013.05.005","journal-title":"Radiother Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/jrr\/rraa112","article-title":"A surveillance study of patterns of reirradiation practice using external beam radiotherapy in Japan","volume":"62","author":"Yamazaki H","year":"2021","unstructured":"Yamazaki H, Suzuki G, Aibe N, Nakamura S, Yoshida K, Oh R. A surveillance study of patterns of reirradiation practice using external beam radiotherapy in Japan. J Radiat Res. 2021, 62:285-293. 10.1093\/jrr\/rraa112","journal-title":"J Radiat Res"},{"key":"ref9","unstructured":"Kugler M. \"Rare Diseases Legislation Passed\". About.com. (2012). Accessed. October 1, 2012: https:\/\/en.wikipedia.org\/wiki\/Rare_Diseases_Act_of_2002."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda Y","year":"2013","unstructured":"Kanda Y. Investigation of the freely available easy-to-use software 'EZR' for medical statistics. Bone Marrow Transplant. 2013, 48:452-458. 10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.14338\/IJPT-20-00064.1","article-title":"A systematic review on re-irradiation with charged particle beam therapy in the management of locally recurrent skull base and head and neck tumors","volume":"8","author":"Gamez ME","year":"2021","unstructured":"Gamez ME, Patel SH, McGee LA, et al.. A systematic review on re-irradiation with charged particle beam therapy in the management of locally recurrent skull base and head and neck tumors. Int J Part Ther. 2021, 8:131-154. 10.14338\/IJPT-20-00064.1","journal-title":"Int J Part Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2020.01.004","article-title":"Reirradiation of salivary gland tumors with carbon ion radiotherapy at CNAO","volume":"145","author":"Vischioni B","year":"2020","unstructured":"Vischioni B, Dhanireddy B, Severo C, et al.. Reirradiation of salivary gland tumors with carbon ion radiotherapy at CNAO. Radiother Oncol. 2020, 145:172-177. 10.1016\/j.radonc.2020.01.004","journal-title":"Radiother Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2019.04.007","article-title":"Feasibility of re-irradiation using carbon ions for recurrent head and neck malignancies after carbon-ion radiotherapy","volume":"136","author":"Hayashi K","year":"2019","unstructured":"Hayashi K, Koto M, Ikawa H, Hagiwara Y, Tsuji H, Ogawa K, Kamada T. Feasibility of re-irradiation using carbon ions for recurrent head and neck malignancies after carbon-ion radiotherapy. Radiother Oncol. 2019, 136:148-153. 10.1016\/j.radonc.2019.04.007","journal-title":"Radiother Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2020.11.001","article-title":"Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (10B) for recurrent or locally advanced head and neck cancer (JHN002): an open-label phase II trial","volume":"155","author":"Hirose K","year":"2021","unstructured":"Hirose K, Konno A, Hiratsuka J, et al.. Boron neutron capture therapy using cyclotron-based epithermal neutron source and borofalan (10B) for recurrent or locally advanced head and neck cancer (JHN002): an open-label phase II trial. Radiother Oncol. 2021, 155:182-187. 10.1016\/j.radonc.2020.11.001","journal-title":"Radiother Oncol"},{"key":"ref15","article-title":"Malignant Salivary Gland Tumors","author":"Young A","year":"2021","unstructured":"Young A, Okuyemi OT. Malignant Salivary Gland Tumors. StatPearls Publishing, Treasure Island, FL; 2021."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-09-0638","article-title":"Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States","volume":"18","author":"Boukheris H","year":"2009","unstructured":"Boukheris H, Curtis RE, Land CE, Dores GM. Incidence of carcinoma of the major salivary glands according to the WHO classification, 1992 to 2006: a population-based study in the United States. Cancer Epidemiol Biomarkers Prev. 2009, 18:2899-2906. 10.1158\/1055-9965.EPI-09-0638","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00405-020-05998-6","article-title":"Acinic cell carcinoma of the parotid gland: from pathogenesis to management: a literature review","volume":"277","author":"Cavaliere M","year":"2020","unstructured":"Cavaliere M, De Luca P, Scarpa A, Savignano L, Cassandro C, Cassandro E, Iemma M. Acinic cell carcinoma of the parotid gland: from pathogenesis to management: a literature review. Eur Arch Otorhinolaryngol. 2020, 277:2673-2679. 10.1007\/s00405-020-05998-6","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/hed.24382","article-title":"Predictors of survival in parotid adenocarcinoma not otherwise specified: a National Cancer Database study of 3155 patients","volume":"38","author":"Zhan KY","year":"2016","unstructured":"Zhan KY, Huang AT, Khaja SF, Bell D, Day TA. Predictors of survival in parotid adenocarcinoma not otherwise specified: a National Cancer Database study of 3155 patients. Head Neck. 2016, 38:1208-1212. 10.1002\/hed.24382","journal-title":"Head Neck"},{"key":"ref19","article-title":"Cancer of the external auditory canal and temporal bone","volume":"29","author":"Kuhel WI","year":"1996","unstructured":"Kuhel WI, Hume CR, Selesnick SH. Cancer of the external auditory canal and temporal bone. Otolaryngol Clin North Am. 1996, 29:827-852.","journal-title":"Otolaryngol Clin North Am"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/lary.28936","article-title":"Multi-institutional survey of squamous cell carcinoma of the external auditory canal in Japan","volume":"13","author":"Shiga K","year":"2021","unstructured":"Shiga K, Nibu KI, Fujimoto Y, et al.. Multi-institutional survey of squamous cell carcinoma of the external auditory canal in Japan. Laryngoscope. 2021, 13:E870-E874. 10.1002\/lary.28936","journal-title":"Laryngoscope"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/hed.23698","article-title":"Chemoradiation therapy for squamous cell carcinoma of the external auditory canal: a meta-analysis","volume":"37","author":"Takenaka Y","year":"2015","unstructured":"Takenaka Y, Cho H, Nakahara S, Yamamoto Y, Yasui T, Inohara H. Chemoradiation therapy for squamous cell carcinoma of the external auditory canal: a meta-analysis. Head Neck. 2015, 37:1073-1080. 10.1002\/hed.23698","journal-title":"Head Neck"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1080\/00016489.2018.1438662","article-title":"Definitive re-irradiation using intensity-modulated radiation therapy in cancers of the head and neck, focusing on rare tumors","volume":"138","author":"Doi H","year":"2018","unstructured":"Doi H, Uemoto K, Masai N, Tatsumi D, Shiomi H, Oh RJ. Definitive re-irradiation using intensity-modulated radiation therapy in cancers of the head and neck, focusing on rare tumors. Acta Otolaryngol. 2018, 138:750-758. 10.1080\/00016489.2018.1438662","journal-title":"Acta Otolaryngol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1159\/000516801","article-title":"Cancer of the external auditory canal with extensive osteoradionecrosis of the skull base after re-irradiation with particle beams: a case report","volume":"14","author":"Matsuo M","year":"2021","unstructured":"Matsuo M, Yasumatsu R, Yoshida S, Jiroumaru R, Hashimoto K, Wakasaki T, Nakagawa T. Cancer of the external auditory canal with extensive osteoradionecrosis of the skull base after re-irradiation with particle beams: a case report. Case Rep Oncol. 2021, 14:1097-1102. 10.1159\/000516801","journal-title":"Case Rep Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/jso.22023","article-title":"Cutaneous apocrine adenocarcinoma: defining epidemiology, outcomes, and optimal therapy for a rare neoplasm","volume":"105","author":"Hollowell KL","year":"2012","unstructured":"Hollowell KL, Agle SC, Zervos EE, Fitzgerald TL. Cutaneous apocrine adenocarcinoma: defining epidemiology, outcomes, and optimal therapy for a rare neoplasm. J Surg Oncol. 2012, 105:415-419. 10.1002\/jso.22023","journal-title":"J Surg Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0b013e31827a7622","article-title":"An analysis of 2,480 space-occupying lesions of the orbit from 1976 to 2011","volume":"29","author":"Bonavolont\u00e0 G","year":"2013","unstructured":"Bonavolont\u00e0 G, Strianese D, Grassi P, Comune C, Tranfa F, Uccello G, Iuliano A. An analysis of 2,480 space-occupying lesions of the orbit from 1976 to 2011. Ophthal Plast Reconstr Surg. 2013, 29:79-86. 10.1097\/IOP.0b013e31827a7622","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000000531","article-title":"Management of lacrimal gland carcinoma: lessons from the literature in the past 40 years","volume":"32","author":"Woo KI","year":"2016","unstructured":"Woo KI, Yeom A, Esmaeli B. Management of lacrimal gland carcinoma: lessons from the literature in the past 40 years. Ophthal Plast Reconstr Surg. 2016, 32:1-10. 10.1097\/IOP.0000000000000531","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2015.01.002","article-title":"Re-irradiation of adenoid cystic carcinoma: analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapy","volume":"114","author":"Jensen AD","year":"2015","unstructured":"Jensen AD, Poulakis M, Nikoghosyan AV, et al.. Re-irradiation of adenoid cystic carcinoma: analysis and evaluation of outcome in 52 consecutive patients treated with raster-scanned carbon ion therapy. Radiother Oncol. 2015, 114:182-188. 10.1016\/j.radonc.2015.01.002","journal-title":"Radiother Oncol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1159\/000513030","article-title":"A clinical case of 5 times irradiated recurrent orbital hemangiopericytoma","volume":"14","author":"Gordon K","year":"2021","unstructured":"Gordon K, Gulidov I, Gogolin D, et al.. A clinical case of 5 times irradiated recurrent orbital hemangiopericytoma. Case Rep Oncol. 2021, 14:78-84. 10.1159\/000513030","journal-title":"Case Rep Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1177\/11206721211029473","article-title":"Periocular apocrine adenocarcinoma presenting as an orbital mass: clinicopathological features and management in four patients","author":"Ko\u00e7 \u0130","year":"2021","unstructured":"Ko\u00e7 \u0130, Kiratli H, Kapucu Y, S\u00f6ylemezo\u011flu F. Periocular apocrine adenocarcinoma presenting as an orbital mass: clinicopathological features and management in four patients. Eur J Ophthalmol. 2021, 11206721211029473. 10.1177\/11206721211029473","journal-title":"Eur J Ophthalmol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2020.02.008","article-title":"The medical physics management of reirradiation patients","volume":"30","author":"Paradis KC","year":"2020","unstructured":"Paradis KC, Matuszak MM. The medical physics management of reirradiation patients. Semin Radiat Oncol. 2020, 30:204-211. 10.1016\/j.semradonc.2020.02.008","journal-title":"Semin Radiat Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/87421-reirradiation-for-rare-head-and-neck-cancers-orbit-auditory-organ-and-salivary-glands","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:40:16Z","timestamp":1707507616000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/87421-reirradiation-for-rare-head-and-neck-cancers-orbit-auditory-organ-and-salivary-glands"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,28]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.22727","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,28]]}}}